A preponderance of females develop autoimmune disease, including juvenile idiopathic arthritis (JIA), yet the reason for this bias remains elusive. Evidence suggests that genetic risk of disease may be influenced by sex. PTPN22 rs2476601 is associated with JIA and numerous other autoimmune diseases, and has been reported to show female-specific association with type 1 diabetes. We performed main effect and sex-stratified association analyses to determine whether a sex-specific association exists in JIA. As expected, rs2476601 was associated with JIA in our discovery (413 cases and 690 controls) and replication (1008 cases and 9284 controls) samples. Discovery sample sex-stratified analyses demonstrated an association specifically in females (odds ratio (OR) = 2.35, 95% confidence interval (CI) = 1.52-3.63, P = 0.00011) but not males (OR = 0.91, 95% CI = 0.52-1.60, P = 0.75). This was similarly observed in the replication sample. There was evidence for genotype-by-sex interaction (P interaction = 0.009). The association between rs2476601 and JIA appears restricted to females, partly accounting for the predominance of females with this disease.
INTRODUCTION
Juvenile idiopathic arthritis (JIA) is the most common pediatric rheumatic disease, with a prevalence of around 1 in 1000 Caucasian children. 1 Although the etiology of JIA is not well understood, it is clear that genetic and environmental risk factors contribute to disease manifestation. A number of susceptibility loci have now been identified, 2 including the gene encoding the protein tyrosine phosphatase non-receptor type 22 (PTPN22). The PTPN22 single-nucleotide polymorphism (SNP) rs2476601 encodes a substitution of arginine (R) for tryptophan (W) at position 620 (R620W) of the protein, and has the strongest demonstrated association with JIA outside of the HLA region. 2 PTPN22 rs2476601 is widely recognized as a major risk factor for autoimmunity, and has been associated with numerous other autoimmune diseases, such as rheumatoid arthritis, type 1 diabetes and systemic lupus erythematosus. 3 Many autoimmune diseases occur more frequently in females than males, 4 but the reason for this bias remains elusive. Overall, JIA is more common in females. 1 However, JIA encompasses seven clinically and phenotypically heterogeneous subtypes (oligoarticular, rheumatoid factor (RF)-positive and -negative polyarticular, systemic, enthesitis-related, psoriatic and undifferentiated arthritis), and the reported sex ratios differ by subtype. 1 For example, the female preponderance is highest in oligoarticular and polyarticular arthritis, whereas enthesitis-related arthritis occurs more commonly in males. 1 There is evidence to suggest that the effect of genetic factors on disease risk may be influenced by sex. 5, 6 Dimas et al. found that 12-15% of autosomal gene expression quantitative trait loci were sexually dimorphic, and these sex-specific differences in gene regulation are likely to have sex-specific effects on disease. 5, 6 Thus, we hypothesized that some JIA risk loci may affect disease risk differentially in females and males. A female-specific association of PTPN22 rs2476601 with type 1 diabetes has been reported in some, 7 but not all, 8, 9 studies. We therefore sought to determine whether rs2476601 exhibits a sex-specific association in JIA.
RESULTS AND DISCUSSION
The PTPN22 rs2476601 minor allele was associated with JIA in the discovery study sample ( Table 1 ). The association with JIA remained when we adjusted for sex, but was weakened (odds ratio (OR) = 1.63, 95% confidence interval (CI) = 1.18-2.24, P = 0.0028). Subsequent sex stratification revealed a femalespecific association ( Table 1) .
Statistically significant evidence for an interaction between genotype and sex was found (P interaction = 0.009). Comparing models of independent SNP and sex effects with SNP-sex interaction effects suggested interaction was the best fit for the data (likelihood ratio test P = 0.007).
We determined the population attributable fraction (the proportion of cases that would not occur if the factor were eliminated) for rs2476601 to be 0% for males and 8% for females in the discovery sample, demonstrating the increased importance of this genetic factor to JIA risk in females.
A 'pooled-controls' analysis that compared cases of one sex with all controls and cases of the opposite sex, 10 further supported a female-specific association of rs2476601 with total JIA, and the association was strengthened (females vs males+controls: OR = 2.09, 95% CI = 1.52-2.88, P = 6.1 × 10 − 6 ; males vs females +controls: OR = 0.76, 95% CI = 0.46-1.27, P = 0.30).
The frequency of rs2476601 is known to differ by ethnicity. We therefore performed a sensitivity analysis using a Europeanrestricted 11 subset of the CLARITY sample (n case = 250 and n control = 423). Overall, and sex-specific, associations remained evident ( Supplementary Table 1 ), as did statistically significant evidence for an interaction between genotype and sex (P interaction = 0.02).
In those JIA subtypes with a female bias, a female-specific association, or a trend toward association, with rs2476601, was apparent ( Table 1) . Subtypes with a male bias showed no association with the variant, and no sex-specific associations ( Table 1) . We performed a restricted analysis of only the two most common subtypes-oligoarticular and polyarticular RF negative, in line with past work to identify genetic associations 2 ( Supplementary Table 2 ), and also an analysis of all subtypes excluding systemic JIA, which is particularly clinically distinct 1 (Supplementary Table 3 ). The results of these analyses were not materially different to the total JIA sample analyses.
Both the main effect and female-specific associations of rs2476601 with JIA were replicated in an independent case-control sample (Children's Hospital of Philadelphia sample; Table 1 ). In the JIA subtype-specific analyses, a similar pattern of association was also demonstrated (Table 1) , although only the polyarticular RF-negative (and undifferentiated) subtype showed a statistically significant (P o0.05) female-specific association.
Our findings, consistent across two independent case-control data sets, demonstrate sex as an important determinant of the association of JIA with PTPN22 rs2476601. We observed that the association of rs2476601 with JIA is specific to females, and rs2476601 appears to interact with sex to modify JIA risk. Our findings are in accordance with previous reports of a female-specific association of PTPN22 with type 1 diabetes. 7 Therefore, this variant may contribute to the mechanisms by which a preponderance of females develop JIA, and possibly autoimmune diseases more generally.
Our current understanding of the functional consequences of rs2476601 does not shed light on any obvious sex-specific biological mechanisms. Initially, the variant was solely implicated in altered T-cell function, where it leads to increased negative regulation of T-cell signaling. 12 More recently, evidence has accrued implicating the variant in the disruption of B-cell signaling and tolerance. 13 However, the impact of this amino-acid substitution on protein structure and function is predicted to be benign and tolerated, 2 perhaps suggesting that consequent mechanistic changes are of a regulatory nature rather than functional. Indeed, the SNP is highly conserved, 2 has a regulomeDB score of 2b suggesting it is likely to affect transcription factor binding, and is in high linkage disequilibrium with an additional PTPN22 variant (rs6679677 r 2 = 0.93) that is proposed to have a regulatory impact. 2 The functional or regulatory consequences of this variant warrant further investigation.
Sex hormones are known to directly influence the immune system, 4 and may mediate sex-specific disease risk. This hypothesis has been considered in relation to PTPN22 rs2476601 through examining allele-specific expression in peripheral blood mononuclear cells from healthy males, females and pregnant females. 14 No differences in expression were found between these groups. In children, adrenarche begins at around 8 years of age. 15 We saw no appreciable difference in the patterns of association between JIA and rs2476601 when we divided cases by an age at diagnosis of less than or greater than 8 years (data not shown). Furthermore, the two subtypes apparently driving the female-specific association of PTPN22, oligoarticular and polyarticular RF-negative JIA, commonly occur at an age consistent with pre-adrenarche. 1 Collectively, these data do not lend support to a role for postadrenarche female sex hormones in the female-specific association of PTPN22 with JIA.
A strength of our study is replication of our finding in independent data sets, significantly reducing the likelihood of reporting a type 1 error. Given the small sample sizes, our ability to comprehensively investigate subtype-and sex-specific associations was limited. Despite this, the patterns of association we observed do concur with subtype-specific sex ratios, supporting our main finding. In addition, previously reported subtype-specific associations of JIA with rs2476601 found significant associations only in subtypes with a female bias. 16 In both the previously published data and our study, the more rare subtype samples were too small to draw any firm conclusions.
Overall, our results demonstrate that the association between PTPN22 rs2476601 and JIA appears specific to females, and that this SNP interacts with sex to determine JIA risk. We suggest that, given both a preponderance of females and an association with PTPN22 are common observations in autoimmune diseases generally, our findings may be relevant to other diseases. We also suggest that sex-specific analyses may be worthwhile for those autoimmune diseases for which association of PTPN22 with disease has not been previously confirmed. The biological mechanism for this gene-by-sex interaction is yet to be elucidated, but further investigation will likely shed light on the biological basis for the preponderance of females with autoimmune disease.
MATERIALS AND METHODS

Discovery sample
Participants for the discovery sample were drawn from the Australian CLARITY JIA case-control biobank described previously. 11, 17 Cases were diagnosed by a pediatric rheumatologist and classified into subtypes according to their clinical course. Participants included 413 cases (67% female, mean age 9.1 years) and 690 controls (42% female, mean age 7.1 years). The Royal Children's Hospital and Monash Medical Centre Human Research Ethics Committees approved this study, and informed consent was obtained from all participants. rs2476601 was genotyped in CLARITY cases and controls using the Sequenom MassARRAY system as previously described. 18 Analyses were performed using Stata v13 (StataCorp, College Station, TX, USA). Logistic regression was used to generate ORs and 95% CIs for the association of rs2476601 (additive model) with 'total' JIA and individual subtypes. For analyses where logistic regression could not be performed because of the absence of the minor allele in cases, we used the Woolf method with a continuity correction delta = 0.5 (also known as the Gart method) to estimate ORs and 95% CIs, and Fisher's exact test to determine the P-value. We adjusted for sex, and then stratified each analysis by sex to assess the evidence of association in females and males separately. We tested for genotype-by-sex interaction using a product term in the logistic regression model. Population attributable fraction attributable to the genotype was calculated separately for males and females according to the method described by Rothman. 19 We utilized an additional approach to test for sex-specific association by adopting the pooled-control method according to Myers et al. to detect male-and female-driven genotype-by-sex interactions in a case-control study. 10 In this analysis, cases of one sex were compared with all controls and cases of the opposite sex (female analysis: 278 cases and 825 males+controls; male analysis: 135 cases and 968 females+controls).
Replication sample
Samples for independent replication analysis were obtained from an independent JIA case-control collection from the USA and Norway, genotyped at the Children's Hospital of Philadelphia, as described previously. 11 Genotype data for rs2476601 were extracted from genome-wide SNP data for 1008 cases (69% female) and 9284 controls (46% female) of European ancestry. Logistic regression was performed in PLINK 20 to test for association between rs2476601, total JIA and JIA subtypes, including sex-adjusted and sex-stratified analyses.
